Study Conducted By:
Jonathan Rosenblum, DPM.
57-year-old diabetic male.
Patient is a post transmetatarsal amputation (TMA) and the stump hasn’t been healing at all prior to treatment with Inula-based product. Uncontrolled blood sugar levels. Prior standard of care wound treatment was ineffective.
Full thickness ulceration with fibrotic tissue noted. Unhealthy granulation and biofilm present due to the chronicity of the wound.
Use of Lavior’s Inula-based wound product on a daily basis.
Product(s) Used in Study:
D-Care Diabetic Wound Care.
4 Weeks – 4 Week Predictive Marker Study.
Wound size: 13.8 cm. Early stage 3 wound. Fibrotic tissue is evident with unhealthy granulation tissue. Presence of biofilm due to the chronicity of the wound.
AFTER 1 WEEK OF TREATMENT
The granulation tissue is taking on more of a deep red color. The wound is decreasing in size. The wound edges are demarcating and becoming less adherent to the wound therefore debridement can be possible.
AFTER 2 WEEKS OF TREATMENT
The size of the wound is continuing to decrease. The biofilm has been disrupted. Eschar is continuing to form around the wound.
AFTER 4 WEEKS OF TREATMENT
Wound size: 5.6 cm. The borders are free of eschar. Epithelial tissue surrounds the healthy granulation tissue. The wound size has diminished significantly.
During this 4-week period, wound closure is at 59%. As evident from the photos, the healthy granulation tissue has replaced the fibrotic, non-healing wound due to the healing properties of the LAVIOR D-Care product.